GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lannett Co Inc (OTCPK:LCINQ) » Definitions » Shiller PE Ratio

Lannett Co (Lannett Co) Shiller PE Ratio : (As of May. 07, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Lannett Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lannett Co Shiller PE Ratio Historical Data

The historical data trend for Lannett Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lannett Co Shiller PE Ratio Chart

Lannett Co Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.74 35.60 150.01 - -

Lannett Co Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lannett Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Lannett Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lannett Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lannett Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lannett Co's Shiller PE Ratio falls into.



Lannett Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lannett Co's E10 for the quarter that ended in Mar. 2023 is calculated as:

For example, Lannett Co's adjusted earnings per share data for the three months ended in Mar. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-9.84/127.3478*127.3478
=-9.840

Current CPI (Mar. 2023) = 127.3478.

Lannett Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201306 0.480 98.518 0.620
201309 -0.800 98.790 -1.031
201312 1.840 98.326 2.383
201403 2.520 99.695 3.219
201406 2.560 100.560 3.242
201409 3.760 100.428 4.768
201412 4.840 99.070 6.222
201503 3.880 99.621 4.960
201506 3.640 100.684 4.604
201509 3.560 100.392 4.516
201512 1.440 99.792 1.838
201603 -0.600 100.470 -0.761
201606 0.400 101.688 0.501
201609 -3.200 101.861 -4.001
201612 0.880 101.863 1.100
201703 1.600 102.862 1.981
201706 0.600 103.349 0.739
201709 1.400 104.136 1.712
201712 1.480 104.011 1.812
201803 1.320 105.290 1.597
201806 -1.200 106.317 -1.437
201809 -30.600 106.507 -36.588
201812 1.280 105.998 1.538
201903 1.080 107.251 1.282
201906 -0.800 108.070 -0.943
201909 -1.280 108.329 -1.505
201912 0.520 108.420 0.611
202003 -1.720 108.902 -2.011
202006 -1.000 108.767 -1.171
202009 -0.680 109.815 -0.789
202012 -17.440 109.897 -20.209
202103 -0.720 111.754 -0.820
202106 -18.000 114.631 -19.997
202109 -2.240 115.734 -2.465
202112 -8.040 117.630 -8.704
202203 -3.450 121.301 -3.622
202206 -9.200 125.017 -9.372
202209 -2.720 125.227 -2.766
202212 -3.520 125.222 -3.580
202303 -9.840 127.348 -9.840

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lannett Co  (OTCPK:LCINQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lannett Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Lannett Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lannett Co (Lannett Co) Business Description

Traded in Other Exchanges
N/A
Address
1150 Northbrook Drive, Suite 155, Trevose, PA, USA, 19053
Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.
Executives
John C Chapman director 9000 STATE ROAD, PHILADELPHIA PA 19136
Timothy C Crew officer: Chief Executive Officer 9000 STATE ROAD, PHILADELPHIA PA 19136
Patrick G Lepore director 17-17 ROUTE 208 N, FAIRLAWN NJ 07410
Melissa Rewolinski director 9000 STATE ROAD, PHILADELPHIA PA 19136
Jeffrey Farber officer: Secretary
Samuel H Israel officer: Chief Legal Officer 9000 STATE ROAD, PHILADELPHIA PA 19136
John Abt officer: Vice President of Quality 9000 STATE ROAD, PHILADELPHIA PA 19136
John Kozlowski officer: Chief Operating Officer 9000 STATE ROAD, PHILADELPHIA PA 19136
David A Drabik director 9000 STATE RD, PHILADELPHIA PA 19136
Paul Taveira director 9000 STATE ROAD, PHILADELPHIA PA 19136
Albert Iii Paonessa director 9852 NW 2ND COURT, PLANTATION FL 33324
Kevin Smith other: Vice President
Maureen Cavanaugh officer: Senior Vice President and CCOO 9000 STATE ROAD, PHILADELPHIA PA 19136
David Farber officer: Treasurer
Arthur P Bedrosian officer: President P O BOX D 1400, POMONA NY 10970